Drug profile · INN
mepenzolate bromide
CANTIL
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
mepenzolate bromide (CANTIL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN mepenzolate bromide
Brand CANTIL
Route ORAL
Formulation SOLUTION
Frequently asked questions
What is mepenzolate bromide?
mepenzolate bromide (CANTIL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for mepenzolate bromide?
CANTIL is a marketed brand name for mepenzolate bromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mepenzolate bromide?
mepenzolate bromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.